American Heart Journal setting of left ventricular failure, the preejection period lengthens while the ejection time diminishes.2-4 Second, it has become increasingly apparent that parameters of isovolumic relaxation are also abnormal under these circumstances.5-14 Thus, it was postulated that an "isovolumic index," as defined above, might be abnormal in appropriate patient subgroups and might be more sensitive in detecting these patients noninvasively than the traditional systolic time index (ratio of preejection time to ejection time) which ignores abnormalities of isovolumic relaxation.
Initial patient studies,' demonstrated that the isovolumic index was abnormal in those with congestive cardiomyopathy and also in a substantial proportion with stable coronary artery disease. Despite these encouraging results, it was recognized that components of the index may be affected by heart rate and loading conditions.'s8, 15-18 These possible effects require study before the potential clinical significance of directional changes in the isovolumic index secondary to ischemialg or cardioactive drugs can be determined. Thus, the purpose of this investigation was to assess potential changes in the isovolumic index secondary to alterations of heart rate, preload, and afterload.
METHODS
Seventeen mongrel dogs of either sex (25.2 * 4.2 kg) were anesthetized with 35 mg/kg of sodium pentobarbital, intubated, and ventilated with a Harvard respirator. A left thoracotomy and left carotid arteriotomy were performed. The heart was supported in a preicardial cradle and high-fidelity micromanometers (No. 5F, Millar Instruments, Jnc, Houston Texas) were inserted via a left carotid arteriotomy into the ascending aorta, via a left ventricular apical stab wound into the left ventricle, and via a left atriotomy into the left atrium and then through the mitral valve into the left ventricle. The catheters were made equisensitive by matching the systolic blood pressure readings of the left ventricular and the aortic manometers and by matching the high-gain left ventricular diastolic pressures of the left atria1 and left ventricular catheters. Once achieved, the left atria1 catheter was withdrawn through the mitral valve into the left atrium. Frequent checks for zero drift were made throughout the experiments. Left atria1 pacing wires were sutured in place and were attached to an AV-120 Bloom stimulator (Bloom and Associates, Reading, Pa.). A pair of subendocardial ultrasonic crystals were placed in the distribution of the left anterior descending coronary artery in the mid-equatorial plane of the ventricle. These were attached to a sonomicrometer 120 (Triton Technology, San Diego, Calif.), which was interfaced to a Tektronix 2213A oscilloscope (Tektronix, Inc., Beaverton, Or.). Proper crystal alignment was confirmed by oscilloscopic display of the crystal signals and by direct inspection at the conclusion of the experiment. All signals were recorded on an eight-channel Gould 2800s recorder (Gould Recording Systems, Cleveland, Ohio), and reported values are averages from four to six beats recorded at 200 mm/set paper speed during steady states.
Continuous recordings of left ventricular pressure, rate of change of pressure (dP/dt), aortic and atria1 pressure, segment lengths, and ECG 'were made (Fig. 1) . Left ventricular end-diastolic pressures were measured at the time when dP/dt became positive, and this was considered the onset of isovolumic contraction. End systole was taken at peak negative dP/dt, and this was considered the beginning of isovolumic relaxation.2U
The isovolumic contraction time was determined as the time from end-diastolic pressure to peak positive dP/dt"' (Fig. 2) . The ejection time was determined as the time from peak positive to peak negative dP/dt.20." The isovolumic relaxation time was taken from peak negative dP/dt to the point where left atria1 and left ventricular diastolic pressures crossed over.22'Z6 The isovolumic index was defined as (IVC + IVR)/ET, where IVC = isovolumic contraction time, IVR = isovolumic relaxation time, and ET = left ventricular ejection time. The systolic time index was defined as IVC/ET. Segment shortening was defined as segment excursion between end diastole and end systole divided by end-diastolic length and multiplied by 100. To determine directional changes in relaxation, an estimate of the isovolumic relaxation time constant was determined by dividing the left ventricular pressure at peak negative dP/dt by peak negative dP/dt." '('I The experimental protocol was randomized into four phases with ample time between each to reattain steadystate hemodynamics. The effects of changing heart rate was assessed by incremental atria1 pacing in steps of approximately 10 bpm at five successive levels. The effects of volume loading were assessed by infusing saline in 50 to 150 cc amounts to obtain five increasing levels of left ventricular end-diastolic pressure. Afterload was altered by three incremental infusions of nitroprusside and phenylephrine in order to cause steady-state reductions and elevations, respectively, of systolic pressure of approximately 10 to 15 mm Hg per stage.
All results were analyzed by repeated measures analysis of variance. When overall significance was detected, a Bonferonni test was utilized to determine which stages were significantly different from controL3' A p value of less than 0.05 was considered significant. Results are reported as mean rt standard deviation. Data from all four phases were combined for a stepwise regression procedure to determine which combination of parameters best explained the variations in the isovolumic index. When hemodynamic instability, arrhythmias, non-steadystate conditions, crystal misalignment, or excessive zerodrift of pressure measurements were found, the data from all stages of that experiment were excluded from analysis. Full complements of data at each desired level were obtained in 12 dogs for the atria1 pacing protocol, in eight dogs during saline loading, in 13 dogs during nitroprusside infusion, and in 11 dogs during phenylephrine infusion. 
RESULTS
Atrial pacing (n = 12). Table I summarizes the results of the atrial pacing protocol. Stepwise increments in heart rate occurred from control values of 129 -t 17 to 177 + 17 bpm. Left ventricular enddiastolic pressure and systolic blood pressure did not change. Peak negative dP/dt and the isovolumic relaxation time constant also showed no significant changes. A rate-dependent increase in peak positive dP/dt and deterioration in segment shortening were noted at the highest levels of pacing. All time intervals progressively shortened with increasing heart rate, and this was greatest for the ejection time and least for the isovolumic contraction time. This resulted in a small but significant increase in the systolic time index (IVCYET). Although a downward trend in the isovolumic index was noted, these changes were not significant. Excluding the last two = rate of pressure change with respect to time, T is the isovolumic relaxation time constant. *p < 0.05 "S control. tp < 0.01 "S control. $p < 0.001 "S control.
rates of extreme tachycardia when fractional shortening was mildly impaired, the isovolumic index showed no significant change over a heart rate range of approximately 30 bpm, whereas the systolic time index showed a very mild prolongation.
Saline loading (n = 8). Left ventricular end-diastolic pressure changed significantly in a stepwise fashion from 8 +_ 2 to 16 +_ 2 mm Hg (Table II) . Heart rate showed no significant change, whereas systolic blood pressure rose significantly with the highest infusions. The elevation during stage four, however, did not reach statistical significance. Peak positive dP/dt was elevated relative to control during the last three infusions. Peak negative dP/dt remained constant, whereas the isovolumic relaxation time constant increased from 40 + 13 msec to 45 +-11 and 46 +-12 msec during the fourth and fifth stages, respectively. Segment shortening showed the expected improvement with volume loading. The ejection time showed progressive prolongation in the face of progressive shortening of the isovolumic contraction time and a constant isovolumic relaxation time. This caused a significant decrease in both the systolic time index and the isovolumic index (Fig. 3 ). These changes were significantly different from control, even during the first stage of infusion when all other parameters except enddiastolic pressure remained unchanged.
Nitroprusside infusion (n = 13). Table III demonstrates the progressive fall in systolic blood pressure achieved with nitroprusside infusion. This was associated with a 10 to 12 bpm increase in heart rate and a 2 to 3 mm Hg fall in left ventricular end-diastolic pressure. Both peak positive and negative dP/dt fell during this experiment, whereas segment shortening remained constant and the isovolumic relaxation time constant shortened. Significant abbreviation of both isovolumic contraction and relaxation times in conjunction with a constant ejection time resulted in a significant decrease in both the isovolumic index and the systolic time index (Fig. 4) . It should be noted that changes of heart rate in this experiment cannot account for the changes in the isovolumic index or the systolic time index (see Table 1 ). Similarly, the decrease in left ventricular enddiastolic pressure would not be expected to cause a fall in these indices (see Table II ).
Phenylephrine infusion (n = 11). Systolic blood pressure rose significantly by approximately 15 mm Hg in each stage (Table IV, Fig. 4) . A slight but significant fall in heart rate of approximately 7 bpm occurred in the final stage, and the left ventricular end-diastolic pressure rose during the final two stages of the protocol. Peak positive and negative dP/dt showed small increases. Fractional shortening remained constant and the isovolumic relaxation time constant showed the anticipated prolongation, which was paralleled by a significant lengthening of the isovolumic relaxation time. Isovolumic contraction time remained constant and the ejection time showed mildly progressive prolongation that was not significant until stage three. Compared to saline loading, the increase in left ventricular end-diastolic pressure with phenylephrine infusion was not manifested in a progressive shortening of either the isovolumic index or the systolic time index in the face of rising systemic pressure. Both indices remained constant. is the leftventricular end-diastolic pressure, and SBP is the systolic blood pressure. All factors were highly significant at p < 0.0001. Heart rate effects were not significant in this analysis. In contrast, regression of the systolic time index (STI) showed: ST1 = 0.12 + 0.009 HR -0.007 LVEDP + 0.001 SBP, r = 0.63, SEE = 0.05; where HR is heart rate. Thus, the ST1 was slightly more correlated overall with the hemodynamic and heart rate effects.
DISCUSSION
The isovolumic index is determined by a complex interplay between three distinct phases of the cardiac cycle: ejection time, isovolumic contraction time, and isovolumic relaxation time. Therefore, the conclusions of this investigation depend on the validity of the observed directional changes of these intervals. The ejection time has previously been shown to vary inversely with heart rate,2* l5 and to increase with enhanced left ventricular filling,2,32 and enhanced systemic afterload.
Decreased afterload prolongs the left ventricular ejection time if stroke volume is augmented. 34 This study confirmed these findings, except that the ejection time remained constant during nitroprusside infusion. This may have resulted from a lack of increase in stroke volume because of concomitant lowering of filling pressures. This is corroborated by the failure of myocardial shortening to increase (Table IV) .
The isovolumic contraction time revealed only a slight fall with increasing heart rate changes and a decrease during both saline loading and nitroprusside infusion. Again, these findings are in keeping with prior observations. 15, l6 During phenylephrine infusion, however, this interval did not change, in contrast to the work of Harris et a1.35 and Shaver et al 33 that demonstrated prolongation with pressor agents. In the current study, preservation of myocardial shortening by maintenance and enhancement of left ventricular filling may have prevented changes in the stroke volume and, hence, isovolumic contraction time is expected to remain constant (Table III) .36
The third important interval is the isovolumic relaxation time. This interval has been shown to be affected by the level of aortic closing pressure, the left atria1 pressure, and the rate of left ventricular pressure fa11.14s 17,37 In this study, no significant alteration in isovolumic relaxation time was noted during saline infusion despite significant elevations of left ventricular end-diastolic pressures and left atria1 pressures. This can be explained by the offsetting effects of elevated systolic pressure and the prolonged rate of isovolumic relaxation.'4~17~37-39 This was apparent during the phenylephrine infusions, when more marked elevations in systolic pressure were associated with prolongation of the isovolumic relaxation time constant and the isovolumic relaxation time despite an increase in left ventricular enddiastolic pressures. Moreover, the opposite effects were noted during nitroprusside infusion, i.e., isovolumic relaxation time shortened in parallel with a shorter isovolumic relaxation time constant and decreasing systemic pressures. These latter effects offset the mild fall of left ventricular end-diastolic pressure that might have prolonged the isovolumic relaxation period. The effect of heart rate on the isovolumic relaxation time interval is less clearly defined, and investigators have reported no ,-hange,'8, 37,405 41 increases,14 or decreases.13 This interval is partially determined by the rate of fall of left ventricular pressure and the isovolumic relaxation time constant, both of which have been shown to be more rapid with increasing heart rate.38,42 In the current investigation, the isovo!umic relaxation time was not significantly differe.nt with changes in rate of approximately 20 bpm, but 'at higher rates a progressive decrease appeared. These findings cannot be explained by changes in systemic pressures or filling pressures, because these remained constant. In addition, peak negative dP/dt and the isovolumic relaxation time constant were not significantly changed, although the latter tended toward progressive shortening. The use of the pressure crossover point of left ventricular and left atrial pressures may have been less closely related to mitral valve opening during rapid left atria1 pacing than at lower rates.2" Left atria1 pacing caused a very rapid and marked pressure rise in the left atrium. It is conceivable that the rapid pressure rise in the left atrium caused a progressive underestimation of actual mitral valve opening and the end of the isovolumic relaxation period. Thus, the effects of very large increases in heart rate in this study must be considered tentative, whereas observations made within rate changes of approximately 20 bpm above control are in keeping with no significant alteration of either the isovolumic relaxation time or the isovolumic index. The results of multiple regression analysis confirm that heart rate changes do not affect the isovolumic index.
Limited observations in dogs reported in the initial descriptive study of the isovolumic index showed an inverse relation between fractional shortening and the isovolumic index.' Fractional shortening was altered by increasing left ventricular enddiastolic pressures in that study. The results shown in Table II confirm those results and also confirm the speculated preload dependence of the isovolumic index. Moreover, this dependence can be explained by prolongation of the ejection time and shortening of the isovolumic contraction time by saline loading. Although no overall correlation between the isovolumic index and ejection fraction was noted in patients, it is not yet clear whether directional changes in the isovolumic index will show a relationship to changes in shortening in the absence of loading changes; this will require further elucidation. Determination of the isovolumic index in patients at rest failed to reveal any relationship between this index and heart rate or systemic blood pressure.' The current findings confirm the lack of major heart rate effects on the isovolumic index. In contrast, systemic pressure changes did influence the measurement of the isovolumic index, particularly with nitroprusside infusion. This drug brought about a shortening of both isovolumic periods and maintenance of a stable ejection time. Thus, the isovolumic index shortened.
Although the isovolumic index is less correlated overall with hemodynamic and heart rate changes, a comparison of the directional changes in the isovo- kO.15 lumic index and the systolic time index (isovolumic contraction divided by the ejection time) shows that both indexes respond in a very similar fashion to load changes. However, it is clear that the ultimate advantage of the isovolumic index might be in those situations demonstrating selective abnormalities of isovolumic relaxation or when subtle abnormalities of both isovolumic contraction and relaxation are present. Indeed, the isovolumic index has been found to be abnormal in a small group of coronary patients with normal ratios of preejection time to ejection time,' underscoring a potential superiority of the isovolumic index despite similar load dependency.
In conclusion, this study establishes the hemodynamic determinants of the isovolumic index. It has been shown that the index is a load-dependent parameter that is independent of heart rate changes. The index shows a fall with decreasing systemic pressure and with physiologic increases in left ventricular end-diastolic pressure. Minimal change was noted in response to rising systemic pressure. A potential deterioration (prolongation), however, may have been offset by the progressively increased left ventricular end-diastolic pressure during phenylephrine infusion. As with other load-dependent parameters such as the ejection fraction or isovolumic parameters, detailed knowledge of the hemodynamic determinants of the isovolumic index are required before the significance of its directional changes in response to cardioactive drugs or ischemia can be determined.
Thus, this investigation provides the framework for future applications of the isovolumic index in the clinical setting. 
